A Scoping Review of Healthcare Effectiveness Data and Information Set (HEDIS) Substance Use Disorder Measures

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2025 Jan 2

PMID 39745202

Authors

Oliver Ethan Goal

Isca Amanda

Cameron Adams

Maria Adela Grando

Affiliations

Soon will be listed here.

Abstract

Introduction: : There is a need to assess the delivery of interventions to improve substance use disorder (SUD) treatment, as measured by the Healthcare Effectiveness Data and Information Set (HEDIS®) metrics. The goal was to characterize published articles reporting HEDIS® SUD measures and recommend future work on applying and investigating SUD HEDIS® metrics and their effect on SUD treatments.

Materials And Methods: The PRISMA-ScR scoping review protocol was used to find published work and investigate the most common reported baseline characteristics, HEDIS® metric outcomes, and knowledge gaps. Peer-reviewed papers available through PubMed, Academic Search Premier, Elsevier/ScienceDirect, and Medline were searched up to August 14, 2022.

Results: : Twenty-eight articles were included after removing 92 duplications. Twenty-five articles were retrospective cohort studies, two were RCTs, and there was a mixed-method study. SUD metrics were studied in diverse settings, including ED, primary care, mental health care, and SUD specialty care. Twenty-seven papers utilized the Initiation and Engagement of Substance Use Disorder Treatment (IET) measure, and 13 had similar data sources, study populations, and authors. Eight papers presented IET results by substance used, primarily alcohol, cannabis, and opioids.

Conclusions: : More research is needed on the HEDIS® SUD metrics and their usefulness in informing SUD prevention and treatment, policy, and public health outcomes.

References

Garnick D, Horgan C, Mark T, Lee M, Acevedo A, Neager S . The importance of identification when measuring performance in addiction treatment. Subst Abus. 2019; 40(3):263-267. PMC: 6763371. DOI: 10.1080/08897077.2019.1580240. View

Liu Y, Becker A, Mattke S . Association of Adverse Events in Opioid Addiction Treatment With Quality Measure for Continuity of Pharmacotherapy. J Healthc Qual. 2022; 44(3):e38-e43. DOI: 10.1097/JHQ.0000000000000338. View

Harris A, Ellerbe L, Phelps T, Finney J, Bowe T, Gupta S . Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. J Subst Abuse Treat. 2015; 53:16-21. DOI: 10.1016/j.jsat.2015.01.002. View

Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

Regan S, Howard S, Powell E, Martin A, Dutta S, Hayes B . Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description. J Addict Med. 2021; 16(2):216-222. DOI: 10.1097/ADM.0000000000000875. View

Kline-Simon A, Stumbo S, Campbell C, Binswanger I, Weisner C, Haller I . Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings. Subst Abus. 2019; 40(3):278-284. PMC: 6669120. DOI: 10.1080/08897077.2018.1547812. View

Harris A, Humphreys K, Bowe T, Tiet Q, Finney J . Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?. J Behav Health Serv Res. 2008; 37(1):25-39. DOI: 10.1007/s11414-008-9142-2. View

Acevedo A, Lee M, Garnick D, Horgan C, Ritter G, Panas L . Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification. Drug Alcohol Depend. 2017; 183:192-200. PMC: 5803317. DOI: 10.1016/j.drugalcdep.2017.11.009. View

Binswanger I, Carroll N, Ahmedani B, Campbell C, Haller I, Hechter R . The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019; 40(3):292-301. PMC: 6656641. DOI: 10.1080/08897077.2018.1545726. View

10.

Powell S, Saali A, Frere J, Magill E, Krystal H, Serafini R . Design of and outcomes in a student-run free mental health clinic serving the uninsured in East Harlem. BMC Psychiatry. 2022; 22(1):501. PMC: 9321276. DOI: 10.1186/s12888-022-04112-w. View

11.

Garnick D, Horgan C, Acevedo A, Lee M, Panas L, Ritter G . Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State. J Subst Abuse Treat. 2017; 82:93-101. PMC: 5653287. DOI: 10.1016/j.jsat.2017.09.007. View

12.

Yarborough B, Chi F, Green C, Hinman A, Mertens J, Beck A . Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018; 12(4):278-286. DOI: 10.1097/ADM.0000000000000399. View

13.

McCorry F, Garnick D, Bartlett J, Cotter F, Chalk M . Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group. Jt Comm J Qual Improv. 2000; 26(11):633-43. DOI: 10.1016/s1070-3241(00)26054-9. View

14.

Lind PhD B, McCarty PhD D, Gu MS Y, Baker PhD R, John McConnell PhD K . Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients. Subst Abus. 2019; 40(3):285-291. PMC: 6692250. DOI: 10.1080/08897077.2018.1550467. View

15.

Mojtabai R, Graff Zivin J . Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis. Health Serv Res. 2003; 38(1 Pt 1):233-59. PMC: 1360883. DOI: 10.1111/1475-6773.00114. View

16.

Lee M, Horgan C, Garnick D, Acevedo A, Panas L, Ritter G . A performance measure for continuity of care after detoxification: relationship with outcomes. J Subst Abuse Treat. 2014; 47(2):130-9. PMC: 4096006. DOI: 10.1016/j.jsat.2014.04.002. View

17.

Ponnapalli A, Grando A, Murcko A, Wertheim P . Systematic Literature Review of Prescription Drug Monitoring Programs. AMIA Annu Symp Proc. 2019; 2018:1478-1487. PMC: 6371270. View

18.

Garnick D, Horgan C, Lee M, Panas L, Ritter G, Davis S . Are Washington Circle performance measures associated with decreased criminal activity following treatment?. J Subst Abuse Treat. 2007; 33(4):341-52. PMC: 2692984. DOI: 10.1016/j.jsat.2007.03.002. View

19.

Grimes D, Schulz K . An overview of clinical research: the lay of the land. Lancet. 2002; 359(9300):57-61. DOI: 10.1016/S0140-6736(02)07283-5. View

20.

Dunigan R, Acevedo A, Campbell K, Garnick D, Horgan C, Huber A . Engagement in outpatient substance abuse treatment and employment outcomes. J Behav Health Serv Res. 2013; 41(1):20-36. PMC: 3796147. DOI: 10.1007/s11414-013-9334-2. View